A safety review has been conducted by the MHRA following a Yellow Card report concerning a patient who was taking bromocriptine. The review concluded that blood pressure monitoring of patients prescribed with this drug is es…
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.